Last update 11 Jul 2024

Sodium Oligomannurarate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hamput Sodium, Mannut Sodium, Oligomannate
+ [5]
Target
Mechanism
APP inhibitors(Beta amyloid A4 protein inhibitors)
Therapeutic Areas
Active Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
CN (02 Nov 2019),
RegulationConditional marketing approval (CN)
Login to view First Approval Timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Alzheimer Disease
CN
02 Nov 2019
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Cognitive DysfunctionPhase 2
CN
01 Oct 2011
Alzheimer DiseasePhase 1
CN
01 Apr 2014
Parkinson DiseaseDiscovery
US
16 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
818
(xayiezzmxk): difference = -2.15 (95% CI, - 3.07 - - 1.23), P-Value = <0.0001
Positive
17 Mar 2021
Placebo
Phase 2
255
(Sodium Oligo-mannurarate 900mg)
belwqzvsoe(elxpiduuxe) = fibsrxcmmv tyhrrrxcbk (mococdllph, exfxyxklnn - xncygmszgc)
-
27 Jan 2015
(Sodium Oligo-mannurarate 600mg)
belwqzvsoe(elxpiduuxe) = qpdjyjtkpr tyhrrrxcbk (mococdllph, nuexorfzqx - esyqmorxce)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free